Martin Zarba

Calgary, AB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Local control of RCC pancreatic metastases is obtained by angiogenesis inhibitors.

Local control of RCC pancreatic metastases is obtained by angiogenesis inhibitors.

Journal: Acta clinica Belgica
Published: September 03, 2026

Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma.

Clinical and Molecular Validation of the Very Favorable IMDC Risk Group in Metastatic Renal Cell Carcinoma.

Journal: JAMA network open
Published: April 15, 2026

International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma.

International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma.

Journal: Frontiers in oncology
Published: March 10, 2026

Outcomes of Complete Responders From First-line Therapy in Metastatic Renal Cell Carcinoma in the Real World: An Analysis From the International Metastatic Renal Cell Carcinoma Database Consortium.

Outcomes of Complete Responders From First-line Therapy in Metastatic Renal Cell Carcinoma in the Real World: An Analysis From the International Metastatic Renal Cell Carcinoma Database Consortium.

Journal: Clinical genitourinary cancer
Published: January 15, 2026

Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC).

Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC).

Journal: Clinical genitourinary cancer
Published: October 29, 2025

Outcomes of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma Receiving Contemporary or Traditional First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Outcomes of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma Receiving Contemporary or Traditional First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Journal: European urology oncology
Published: August 23, 2025

Comorbidity Burden and Effectiveness of Immunotherapy in Metastatic Renal Cell Carcinoma.

Comorbidity Burden and Effectiveness of Immunotherapy in Metastatic Renal Cell Carcinoma.

Journal: Clinical genitourinary cancer
Published: May 06, 2025

Genomic Landscape in Prostate Cancer in a Latin American Population.

Genomic Landscape in Prostate Cancer in a Latin American Population.

Journal: JCO global oncology
Published: September 30, 2024

Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma.

Efficacy of Treatments After Lenvatinib in Patients with Advanced Renal Cell Carcinoma.

Journal: European urology focus
Published: August 25, 2024

Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review.

Multidisciplinary systemic and local therapies for metastatic renal cell carcinoma: a narrative review.

Journal: Expert review of anticancer therapy
Published: May 30, 2024

First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study.

First-line Systemic Therapy Following Adjuvant Immunotherapy in Renal Cell Carcinoma: An International Multicenter Study.

Journal: European urology
Published: May 01, 2024

Experience of bipolar androgen therapy (BAT) in Argentinian oncology centres.

Experience of bipolar androgen therapy (BAT) in Argentinian oncology centres.

Journal: Ecancermedicalscience
Published: September 05, 2022
Showing 1-12 of 15

Last Updated: 09/26/2026